XML 124 R110.htm IDEA: XBRL DOCUMENT v3.24.0.1
Note 22 - Parent Only Condensed Financial Information - Condensed Statements of Cash Flows (Details) - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Net income $ 42,465,000 $ 64,327,000 $ 56,906,000
Provision for deferred income taxes 216,000 (2,249,000) (1,093,000)
Net cash provided by/(used in) operating activities 51,292,000 93,812,000 202,175,000
Net cash used in investing activities 243,309,000 (260,171,000) (504,181,000)
Issuance of subordinated notes, net of issuance costs 0 0 118,111,000
Redemption of subordinated notes (55,000,000) 0 (50,000,000)
Dividends paid (12,163,000) (10,736,000) (9,947,000)
Common stock repurchased, net of repurchased costs (6,803,000) (19,822,000) (10,540,000)
Proceeds from Stock Options Exercised 295,000 5,476,000 3,475,000
Net cash (used in)/provided by financing activities 53,224,000 (444,465,000) 801,724,000
Increase/(decrease) in cash and cash equivalents 347,825,000 (610,824,000) 499,718,000
Cash and cash equivalents at beginning of period 83,548,000 694,372,000 194,654,000
Cash and cash equivalents at end of period 431,373,000 83,548,000 694,372,000
Parent Company [Member]      
Net income 42,465,000 64,327,000 56,906,000
Net amortization of other 780,000 796,000 724,000
Provision for deferred income taxes (72,000) (57,000) (337,000)
Distributed income in excess of earnings/(undistributed income) of subsidiaries 34,282,000 (72,397,000) (39,168,000)
Change in other assets and liabilities 113,000 216,000 1,645,000
Net cash provided by/(used in) operating activities 77,568,000 (7,115,000) 19,770,000
Purchase of other equity securities, net (490,000) (1,663,000) (380,000)
Net cash used in investing activities (490,000) (1,663,000) (380,000)
Issuance of subordinated notes, net of issuance costs 0 0 118,111,000
Redemption of subordinated notes (55,000,000) 0 (50,000,000)
Dividends paid (12,163,000) (10,736,000) (9,947,000)
Common stock repurchased, net of repurchased costs (6,803,000) (19,822,000) (10,540,000)
Proceeds from Stock Options Exercised 295,000 5,476,000 3,475,000
Net cash (used in)/provided by financing activities (73,671,000) (25,082,000) 51,099,000
Increase/(decrease) in cash and cash equivalents 3,407,000 (33,860,000) 70,489,000
Cash and cash equivalents at beginning of period 43,718,000 77,578,000 7,089,000
Cash and cash equivalents at end of period $ 47,125,000 $ 43,718,000 $ 77,578,000